Lymphoma, Extranodal NK-T-Cell

3 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Lymphoma, Extranodal NK-T-Cell
Treatment and conditionWhere it standsTrials
Dibotatug for lymphoma, extranodal nk-t-cellPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Selinexor, anti-PD-1 antibody plus Golidocitinib for lymphoma, extranodal nk-t-cellTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
XPO1 inhibitor for lymphoma, extranodal nk-t-cellTrial registered, as of 19 Nov 2026 (not yet checked by a person)1